You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.



Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 


Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley

Three books of the series My First Factor Creation are now available for free download

read more 


SIPPET study results published in the “New England Journal of Medicine”

This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world

read more 
  1. CORPORATE - 19-01-2016

    Kedrion Biopharma strengthens its position on the US market

    Granted exclusive rights to commercialize a lifesaving drug in the US

    read more 
  2. CORPORATE - 18-01-2016

    A brand new location for KEDPlasma donors in the very center of Fürth

    Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide

    read more 
  3. CORPORATE - 08-01-2016

    KEDPlasma acquires two plasma centers from ImmunoTek LLC in the US

    The acquisition is part of a five-year growth plan of supplying highest-quality plasma to Kedrion Biopharma

    read more 
  4. EVENTS - 07-12-2015

    Hemophilia A. SIPPET study selected by the American Society of Hematology

    Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies

    read more 


For more information please contact: